CDIA
BSX icon

Capital Directions Investment Advisors’s Boston Scientific BSX Stock Holding History

Capital Directions Investment Advisors’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-60
Closed -$3K – 250
2022
Q1 		$3K Buy
+60
New +$2.6K ﹤0.01% 255

Other funds holding BSX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Capital Directions Investment Advisors's BSX Position: Q2 2022 in Review

Capital Directions Investment Advisors sold out of Boston Scientific (BSX) in Q2 2022, closing a stake of 60 shares — an estimated $3K sold.

Capital Directions Investment Advisors first reported a position in BSX in Q1 2022 and held it in 1 quarter. The position peaked at $3K in Q1 2022. 879 funds tracked by Wall St. Rank hold BSX as of Q2 2022.

  • Capital Directions Investment Advisors reported no remaining Boston Scientific position as of Q2 2022 after selling out during the quarter.
  • Capital Directions Investment Advisors sold 60 Boston Scientific shares in Q2 2022, an estimated $3K.
  • Capital Directions Investment Advisors first reported a position in Boston Scientific in Q1 2022 and held it in 1 quarter.
  • Capital Directions Investment Advisors's Boston Scientific position peaked at $3K in Q1 2022.
  • 879 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2022.

Based on Capital Directions Investment Advisors's 13F filing for Q2 2022, filed 26 Jul 2022.